back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-08-22 18:45 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$324,000
+300,000 vol $1.08 each |
1,050,000 | |
| Filed 2025-07-17 09:02 Tx date 2025-07-15 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,237
+25,500 vol $1.19 each |
25,500 | |
| Filed 2025-07-16 18:14 Tx date 2025-06-25 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-30 10:39 Tx date 2025-06-25 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1 vol |
1 | |
| Filed 2025-06-30 10:38 Tx date 2025-06-25 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$697,500
+750,000 vol $0.93 each |
750,000 | |
| Filed 2025-06-30 10:27 Tx date 2025-06-25 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-30 10:24 Tx date 2025-06-25 |
$ONC
Oncolytics Biotech Inc. |
Aromando, Andrew P.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|